Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy

BACKGROUND: Nephropathy is an important feature of classical Fabry disease, which results in alpha-galactosidase A deficiency and cellular globotriaosylceramide accumulation. We report the safety and efficacy of antiproteinuric therapy with ACE inhibitors or angiotensin II receptor blockers (ARBs) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Warnock, David G, Thomas, Christie P, Vujkovac, Bojan, Campbell, Ruth C, Charrow, Joel, Laney, Dawn A, Jackson, Leslie L, Wilcox, William R, Wanner, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Phenotypes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717450/
https://www.ncbi.nlm.nih.gov/pubmed/26490103
http://dx.doi.org/10.1136/jmedgenet-2015-103471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717450/
https://www.ncbi.nlm.nih.gov/pubmed/26490103
http://dx.doi.org/10.1136/jmedgenet-2015-103471

Ejemplares similares